NewsRx

Search our medical news database

Stroke Gene Therapy

Bcl-2 Transduction Protects Neurons From Ischemia

Published in Gene Therapy Weekly, July 12th, 1999

Bcl-2 transduction helps protect neurons from transient global ischemia.

Research has shown that transient global ischemia can result in selective neuronal damage of hippocampal CA1 neurons. In the Mongolian gerbil animal model, five minutes of bilateral common carotid artery occlusion effectively restricts forebrain blood flow. This results in a delayed neuronal death of CA1 pyramidal cells.

F.J. Antonawich and colleagues from the State University of New York explored gene therapy options for reducing neuronal death caused by transient ischemia ("BCL-2 Transduction, Using a Herpes Simplex Virus Amplicon, Protects Hippocampal Neurons from Transient...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook